PA
RXST icon

Paragon Advisors’s RxSight RXST Stock Holding History

Paragon Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,678
Closed -$1.23M – 89
2025
Q1 		$1.23M Buy
48,678
+10,856
+29% +$323K 0.46% 56
2024
Q4 		$1.3M Buy
37,822
+6,423
+20% +$290K 0.45% 57
2024
Q3 		$1.55M Buy
31,399
+935
+3% +$47.9K 0.5% 55
2024
Q2 		$1.83M Buy
+30,464
New +$1.74M 0.67% 48

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paragon Advisors's RXST Position: Q2 2025 in Review

Paragon Advisors sold out of RxSight (RXST) in Q2 2025, closing a stake of 48,678 shares — an estimated $1.23M sold.

Paragon Advisors first reported a position in RXST in Q2 2024 and held it in 4 quarters. The position peaked at $1.83M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Paragon Advisors reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Paragon Advisors sold 48,678 RxSight shares in Q2 2025, an estimated $1.23M.
  • Paragon Advisors first reported a position in RxSight in Q2 2024 and held it in 4 quarters.
  • Paragon Advisors's RxSight position peaked at $1.83M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Paragon Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.